☰ Category

Immunity to HIV Vaccine Peptides


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Product Out of Stock Subscription

(Notify me when this product is back in stock)

Rs. 3,718

Availability: Out of stock

  • Product Description

The continuing HIV/ AIDS pandemic represent one of the greatest challenges for researchers and clinicians. This book gives an overview of HIV epidemiology and virology while discussing high-risk behavior factors, HIV immunity and diagnosis. The author argues that vaccine studies usually require volunteers who are followed over a long period of time. She further shows that a high risk cohort of exposed seronegative individuals, that was studied in Nairobi - Kenya, could provide background data for planning HIV-1 Phase II and III vaccine trials. The book discusses challenges encountered in the follow-up of such a cohort in a developing country where such studies have not been done before. The author also explains that the measurement of cellular immunogenicity by interferon gamma Elispot assay in exposed seronegative individuals was not effective. Consequently, there is need to improve the assay or use it in combination with other assays. This book is recommended to students and researchers in biomedical sciences especially those interested in HIV vaccinology.

Product Specifications
SKU :COC84677
AuthorMargaret Muturi
Number of Pages116
Publishing Year2013-10-03T00:00:00.000
Edition1 st
Book TypeMedicine
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-10-08 00:00:00
0 Review(s)